• Aucun résultat trouvé

LUNG CANCER IN THE AMERICAS

N/A
N/A
Protected

Academic year: 2022

Partager "LUNG CANCER IN THE AMERICAS"

Copied!
3
0
0

Texte intégral

(1)

Proportion of new cases and deaths from lung cancer in the Americas, 2012

Number of new cases and deaths from lung cancer by sex, 2012 and 2030

Incidence Men Mortality

Incidence Mortality

Women

• In North America, almost half of all lung cancer cases occur in women, whereas in Latin America and the Caribbean almost two thirds of all lung cancer cases occur in men.

• Among women, the number of new lung cancer cases is almost 4 times higher in North America than in Latin America and the Caribbean.

• Among men, the number of new lung cancer cases and deaths is more than 2 times higher in North America than in Latin America and the Caribbean.

• Lung cancer is projected to increase in the Americas, so that by 2030 there will be more than 541,000 new cases and approximately 445,000 deaths.

• Among Latin American women, the number of cases and deaths from lung cancer is expected to almost double by 2030.

• Among men, it is estimated that the number of new lung cancer cases and deaths will increase by around 60% in North America and by 50% in Latin America and the Caribbean.

LUNG CANCER IN THE AMERICAS

Lung cancer is the third most common cancer and the leading cause of cancer deaths in the

Americas, with more than 324,000 new cases and nearly 262,000 deaths each year.

(2)

Lung cancer incidence and mortality age-standardized rates per 100,000, by country and sex, 2012

• In women, lung cancer rates are highest in North America and Cuba, and lowest in the Caribbean.

• In men, lung cancer rates are highest in Uruguay, USA, and Cuba, and lowest in Central America and Bolivia.

• The incidence/mortality ratio is close to one for both men and women in all countries, indicating a very high case-fatality rate for lung cancer.

Women Men

Lung cancer incidence and mortality age-standardized rates (per 100,000) and prevalence of current adult smokers* (%) among women, 2012

(3)

• An estimated 84% of lung cancer deaths in the Americas are attributable to tobacco.

• Countries with high lung cancer incidence are among those with high tobacco smoking prevalence, although there is a time lag between when a country’s lung cancer rates increase due to prevalence of tobacco smoking.

• The incidence of lung cancer in women and men tends to be higher in countries with higher Gross Domestic Product (GDP), although there are notable exceptions, such as Uruguay where tobacco smoking prevalence is among the highest in the region .

Lung cancer age-standardized incidence rate per 100,000, by sex and by country, and in relation to country GDP per capita (current US$), 2012

Sources: GLOBOCAN 2012 (IARC), available from: http://globocan.iarc.fr/ ; The World Bank Group 2014 Indicators; available from:

http://data.worldbank.org/indicator/NY.GDP.PCAP.CD ; PAHO Cancer Country Profiles 2013; WHO Global Report on Mortality Attributable to Tobacco, 2012.; * 2011 GDP per capita (current US$); PAHO Cancer Country Profiles 2013.

Lung cancer incidence and mortality age-standardized rates (per 100,000) and prevalence of current adult smokers* (%) among men, 2012

Références

Documents relatifs

Ces fleurs sont joli…… ; Martine et Line sont infatigabl…… ; Les villages de Provence sont pittoresqu…… ; Les sommets recouvert…… de neige sont magnifiqu…… ; Une

Midi Minuit

Papastefanou, “Radioactivity of tobacco leaves and radi- ation dose induced from smoking,” International Journal of Environmental Research and Public Health, vol.. Hecht,

ABSTRACT This study documents for the first time the clinical and epidemiological characteristics of lung cancer cases in Qatar from 1998 to 2005.. Mean age at diagnosis was

General Assembly, in response to the growing alarm world-wide, earlier set 12 to 26 June next year for the International Conference on Drug Abuse and

Occupational prestige trajectory and the risk of lung and head and neck cancer among men and women in France9. Gwenn Menvielle, Julien Dugas, Jeanna-Eve Franck, Matthieu

Moreover, no differences were observed according to the duration of elapsed time from allergic disease onset to the reference date, with the only exception noted earlier that the